BTIG Assumes Matinas BioPharma Holdings Inc. (MTNB) at Buy
Tweet
Share
E-mailGet Alerts MTNB Hot Sheet
Price: $0.23 --0%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 8
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 8
Join SI Premium – FREE
BTIG analyst Julian Harrison assumes coverage on Matinas BioPharma Holdings Inc. (NYSE: MTNB) with a Buy rating and a price target of $3.00.
For an analyst ratings summary and ratings history on Matinas BioPharma Holdings Inc. click here. For more ratings news on Matinas BioPharma Holdings Inc. click here.
Shares of Matinas BioPharma Holdings Inc. closed at $0.44 yesterday.
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
- Oppenheimer Starts Carriage Services (CSV) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
